Anika Therapeutics, Inc. Cost of Goods Sold (Deprecated 2018-01-31)
Anika Therapeutics, Inc. (ANIK) reported Cost of Goods Sold (Deprecated 2018-01-31) of $8.72 million for the 3-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-02-27
- Anika Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $8.72M, a 15.61% increase year-over-year.
- Anika Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $6.25M, a 25.05% increase year-over-year.
- Anika Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $6.32M, a 4.12% increase year-over-year.
- Anika Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $6.08M, a 12.13% increase year-over-year.
- Anika Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $27.36M, a 13.89% increase from fiscal 2016.
- Anika Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $24.03M, a 14.13% increase from fiscal 2015.
- Anika Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $21.05M, a 0.59% increase from fiscal 2014.
- Anika Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $20.93M, a 8.06% decline from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $8.72M 10-K · filed 2018-02-27 | $14.97M derived: sum of 2 quarters · filed 2018-02-27 | $21.28M derived: sum of 3 quarters · filed 2018-02-27 | $27.36M 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | $6.25M 10-K · filed 2018-02-27 | $12.56M derived: sum of 2 quarters · filed 2018-02-27 | $18.65M 10-Q · filed 2017-10-27 | $26.19M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2017-06-30 | $6.32M 10-K · filed 2018-02-27 | $12.40M 10-Q · filed 2017-07-28 | $19.94M derived: sum of 3 quarters · filed 2018-02-27 | $24.93M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2017-03-31 | $6.08M 10-K · filed 2018-02-27 | $13.62M derived: sum of 2 quarters · filed 2018-02-27 | $18.62M derived: sum of 3 quarters · filed 2018-02-27 | $24.68M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-12-31 | $7.54M 10-K · filed 2018-02-27 | $12.54M derived: sum of 2 quarters · filed 2018-02-27 | $18.60M derived: sum of 3 quarters · filed 2018-02-27 | $24.03M 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $5.00M 10-K · filed 2018-02-27 | $11.06M derived: sum of 2 quarters · filed 2018-02-27 | $16.49M 10-Q · filed 2017-10-27 | $22.78M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $6.07M 10-K · filed 2018-02-27 | $11.49M 10-Q · filed 2017-07-28 | $17.78M derived: sum of 3 quarters · filed 2018-02-27 | $22.96M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $5.42M 10-K · filed 2018-02-27 | $11.71M derived: sum of 2 quarters · filed 2018-02-27 | $16.89M derived: sum of 3 quarters · filed 2018-02-27 | $22.16M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $6.29M 10-K · filed 2017-02-24 | $11.47M derived: sum of 2 quarters · filed 2017-02-24 | $16.74M derived: sum of 3 quarters · filed 2017-02-24 | $21.05M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $5.18M 10-K · filed 2017-02-24 | $5.18M 10-Q · filed 2015-11-03 | $10.45M derived: sum of 2 quarters · filed 2017-02-24 | $14.76M 10-Q · filed 2016-11-01 | $14.76M 10-Q · filed 2015-11-03 | $20.27M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-06-30 | $5.27M 10-K · filed 2017-02-24 | $5.27M 10-Q · filed 2015-08-04 | $9.59M 10-Q · filed 2016-08-01 | $9.59M 10-Q · filed 2015-08-04 | $15.10M derived: sum of 3 quarters · filed 2017-02-24 | $20.82M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-03-31 | $4.31M 10-K · filed 2017-02-24 | $4.31M 10-Q · filed 2015-05-04 | $9.82M derived: sum of 2 quarters · filed 2017-02-24 | $15.55M derived: sum of 3 quarters · filed 2017-02-24 | $20.88M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2014-12-31 | $5.51M 10-K · filed 2016-03-10 | $5.51M 10-K · filed 2015-03-13 | $11.24M derived: sum of 2 quarters · filed 2016-03-10 | $16.57M derived: sum of 3 quarters · filed 2016-03-10 | $20.93M 10-K · filed 2017-02-24 | $20.93M 10-K · filed 2015-03-13 | ||
| 2014-09-30 | $5.72M 10-K · filed 2016-03-10 | $5.72M 10-Q · filed 2014-11-06 | $11.06M derived: sum of 2 quarters · filed 2016-03-10 | $15.42M 10-Q · filed 2015-11-03 | $21.65M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2014-06-30 | $5.33M 10-K · filed 2016-03-10 | $5.33M 10-Q · filed 2014-08-04 | $9.69M 10-Q · filed 2015-08-04 | $15.93M derived: sum of 3 quarters · filed 2016-03-10 | $21.31M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2014-03-31 | $4.36M 10-K · filed 2016-03-10 | $4.36M 10-Q · filed 2014-05-05 | $10.60M derived: sum of 2 quarters · filed 2016-03-10 | $15.97M derived: sum of 3 quarters · filed 2016-03-10 | $22.29M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2013-12-31 | $6.24M 10-K · filed 2015-03-13 | $11.61M derived: sum of 2 quarters · filed 2015-03-13 | $17.92M derived: sum of 3 quarters · filed 2015-03-13 | $22.77M 10-K · filed 2016-03-10 | $22.77M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | $5.38M 10-K · filed 2015-03-13 | $11.69M derived: sum of 2 quarters · filed 2015-03-13 | $16.53M 10-Q · filed 2014-11-06 | $23.80M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | $6.31M 10-K · filed 2015-03-13 | $11.15M 10-Q · filed 2014-08-04 | $18.42M derived: sum of 3 quarters · filed 2015-03-13 | $25.64M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | $4.84M 10-K · filed 2015-03-13 | $12.11M derived: sum of 2 quarters · filed 2015-03-13 | $19.33M derived: sum of 3 quarters · filed 2015-03-13 | $27.42M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $7.27M 10-K · filed 2014-03-13 | $14.49M derived: sum of 2 quarters · filed 2014-03-13 | $22.58M derived: sum of 3 quarters · filed 2014-03-13 | $28.99M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | $7.22M 10-K · filed 2014-03-13 | $15.31M derived: sum of 2 quarters · filed 2014-03-13 | $21.72M 10-Q · filed 2013-11-05 | $28.85M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $8.08M 10-K · filed 2014-03-13 | $14.50M 10-Q · filed 2013-08-06 | $21.63M derived: sum of 3 quarters · filed 2014-03-13 | $29.02M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $6.41M 10-K · filed 2014-03-13 | $13.54M derived: sum of 2 quarters · filed 2014-03-13 | $20.94M derived: sum of 3 quarters · filed 2014-03-13 | $27.59M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $7.13M 10-K · filed 2013-03-14 | $14.52M derived: sum of 2 quarters · filed 2013-03-14 | $21.18M derived: sum of 3 quarters · filed 2013-03-14 | $26.78M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $7.39M 10-K · filed 2013-03-14 | $14.05M derived: sum of 2 quarters · filed 2013-03-14 | $19.66M 10-Q · filed 2012-11-08 | $26.36M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | $6.66M 10-K · filed 2013-03-14 | $12.26M 10-Q · filed 2012-08-07 | $18.96M derived: sum of 3 quarters · filed 2013-03-14 | $25.07M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | $5.60M 10-K · filed 2013-03-14 | $12.31M derived: sum of 2 quarters · filed 2013-03-14 | $18.42M derived: sum of 3 quarters · filed 2013-03-14 | $24.31M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2010-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $12.81M derived: sum of 2 quarters · filed 2013-03-14 | $18.70M derived: sum of 3 quarters · filed 2013-03-14 | $23.83M 10-K · filed 2013-03-14 | ||||
| 2010-09-30 | $6.11M 10-Q · filed 2011-11-04 | $12.00M derived: sum of 2 quarters · filed 2011-11-04 | $17.12M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $5.89M 10-Q/A · filed 2011-08-10 | $11.02M 10-Q/A · filed 2011-08-10 | ||||||
| 2009-12-31 | $13.67M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |